Skip to content

Clinical trials

Peripheral Arterial Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Arterial Disease Country / region: Canada Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20081
20101
20112
20125
20131
20145
20152
20161
20172
20184
20194
20201
20213
20245
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Recruiting7
Terminated5
Active, not recruiting2
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Manitoba4
Bayer3
CSL Behring2
Eli Lilly and Company2
Hoffmann-La Roche2
Laval University2
McMaster University2
Abbott Medical Devices1
Amgen1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Arterial Disease43
Chronic Limb-Threatening Ischemia8
Coronary Artery Disease8
Atherosclerosis6
Peripheral Vascular Diseases6
Cardiovascular Diseases5
Diabetes Mellitus, Type 24
Myocardial Infarction4
Heart Diseases3
Intermittent Claudication3

Trials

Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.